"The US Food and Drug Administration (FDA) has approved a foam containing calcipotriene and betamethasone dipropionate (Enstilar, Leo Pharma Inc) for topical treatment of plaque psoriasis in adults 18 years of age and older, according to a "...
DOSAGE AND ADMINISTRATION
Apply a thin film of CUTIVATE Ointment (fluticasone propionate ointment) to the affected skin areas twice daily. Rub in gently.
CUTIVATE Ointment (fluticasone propionate ointment) should not be used with occlusive dressings.
Geriatric Use: In studies where geriatric patients (65 years of age or older, see PRECAUTIONS) have been treated with CUTIVATE Ointment (fluticasone propionate ointment) , safety did not differ from that in younger patients; therefore, no dosage adjustment is recommended.
CUTIVATE Ointment (fluticasone propionate ointment) , 0.005% is supplied in:
15-gtubes (NDC 0173-0431-00)
30-g tubes (NDC 0173-0431-01)
60-g tubes (NDC 0173-0431-02)
Store between 2° and 30°C (36° and 86°F).
GlaxoSmithKline, Research Triangle Park, NC 27709. December 2001. FDA rev date: 1/18/2002This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/29/2008
Additional Cutivate Ointment Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.